Myovant Sciences Ltd (MYOV)
BMG637AM1024 - Common Stock
| MRQ (2022-12-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | 2020 (2020-3-31) | 2019 (2019-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 250.59M | 406.70M | 674.50M | 76.60M | 156.10M | |||
| Marketable Securities | 23.85M | 27.48M | 10.40M | 3.00M | N/A | |||
| Receivables | 44.02M | 23.88M | 3.60M | 0.00 | 500.00K | |||
| Inventories | 30.08M | 7.58M | 2.60M | N/A | N/A | |||
| Other Current Assets | 38.05M | 22.50M | 13.50M | 8.30M | 10.20M | |||
| Total Current Assets | 386.59M | 488.14M | 704.60M | 87.90M | 166.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 9.64M | 10.90M | 13.00M | 13.60M | 2.10M | |||
| Other Non-Current Assets | 7.29M | 20.96M | 7.40M | 4.40M | 4.10M | |||
| Total Non-Current Assets | 16.93M | 31.87M | 20.40M | 18.00M | 6.20M | |||
| TOTAL ASSETS | 403.52M | 520.01M | 725.00M | 105.90M | 173.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 6.10M | |||
| Accrued Expenses | 90.04M | 70.74M | 46.40M | 30.60M | 54.70M | |||
| Accounts Payable | 12.22M | 12.25M | 17.80M | 15.30M | 11.00M | |||
| Other Current Liabilities | 143.50M | 167.34M | 217.10M | 40.00M | 100.00K | |||
| Total Current Liabilities | 245.75M | 250.33M | 281.30M | 85.90M | 72.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 358.70M | 358.70M | 358.70M | 113.70M | 93.20M | |||
| Other Non-Current Liabilities | 357.21M | 384.46M | 439.00M | 14.60M | 3.40M | |||
| Total Non-Current Liabilities | 715.91M | 743.16M | 797.70M | 128.30M | 96.60M | |||
| TOTAL LIABILITIES | 961.66M | 993.49M | 1.08B | 214.20M | 168.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.38B | -1.25B | -1.05B | -791.00M | -502.00M | |||
| Additional Paid In Capital | 835.75M | 795.93M | 709.50M | 684.40M | 505.90M | |||
| Common Shares | 2.00K | 2.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -17.29M | -17.29M | -17.30M | -1.60M | 500.00K | |||
| Shares Outstanding | 97.03M | 94.86M | 91.00M | 89.80M | 72.10M | |||
| Tangible Book Value per Share | -5.75 | -4.99 | -3.89 | -1.21 | 0.06 | |||
| Total Shareholders' Equity | -558.14M | -473.48M | -354.00M | -108.30M | 4.30M | |||
| TOTAL LIABILITIES AND EQUITY | 403.52M | 520.01M | 725.00M | 105.90M | 173.00M | |||
| Statistics | ||||||||
| Debt/Equity | -0.64 | -0.76 | -1.01 | -1.05 | 21.67 | |||
| Current Ratio | 1.57 | 1.95 | 2.50 | 1.02 | 2.32 | |||
| Return On Assets (ROA) | -45.54% | -39.61% | -35.19% | -272.89% | -158.12% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | N/A | -6361.63% | |||
All data in USD